Targeted treatment of psoriasis with adalimumab: a critical appraisal based on a systematic review of the literature.
Psoriasis is a chronic inflammatory disease affecting 2% to 3% of the population in Western countries. Psoriasis is associated with limited quality of life, cardiovascular disease, and depression. The approval of injectable biological agents has revolutionized the management of moderate to severe psoriasis. Adalimumab is a human monoclonal antibody against tumor necrosis factor (TNF) alpha approved for moderate-to-severe plaque-type psoriasis and psoriatic arthritis (PsA). This systematic review summarizes the evidence concerning the efficacy, clinical effectiveness, safety, and cost-effectiveness of adalimumab in the treatment of psoriasis. Five randomized controlled trials demonstrated the efficacy of adalimumab in moderate-to-severe plaque-type psoriasis and PsA with PASI-75 response rates of 53% to 80% and ACR-20 response rates of 39% to 58% after 12 to 16 weeks of treatment. In clinical practice patients who have not responded to one TNF antagonist may respond to another TNF antagonist. Adalimumab has similar or better cost-effectiveness than other biologics, but is less efficient than methotrexate and cyclosporine. Adalimumab is generally well tolerated. Patients should be evaluated for active/latent tuberculosis, serious infections, and other contraindications prior to initiation of adalimumab therapy. Future studies should investigate the comparative efficacy of adalimumab and other biologic and prebiologic agents. Recently established registries will yield additional data on the effectiveness and long-term safety of adalimumab.
Schmitt
Jochen
J
Department of Dermatology, Medical Faculty Carl Gustav Carus, Technische Universität Dresden, Germany. jochen.schmitt@uniklinkum-dresden.de
Wozel
Gottfried
G
Lancet. 2008 May 17;371(9625):1675-84
18486740
J Eur Acad Dermatol Venereol. 2007 Sep;21(8):1105-6
17714134
Vaccine. 2003 Jul 28;21(24):3365-9
12850341
Clin Exp Dermatol. 2007 Sep;32(5):593-4
17692063
J Investig Dermatol Symp Proc. 2004 Mar;9(2):136-9
15083780
Br J Dermatol. 2009 Jun;160(6):1264-72
19120346
J Eur Acad Dermatol Venereol. 2008 Mar;22(3):380-2
18269613
Clin Exp Immunol. 1993 Nov;94(2):354-62
8222328
J Immunol. 2005 Jul 1;175(1):5-14
15972624
J Dermatolog Treat. 2008;19(3):185-7
18569276
Int Immunopharmacol. 2002 Apr;2(5):653-72
12013505
Rheumatology (Oxford). 2007 Jan;46(1):93-6
16720636
Arthritis Rheum. 1995 Jun;38(6):727-35
7779114
Eur J Epidemiol. 2004;19(3):225-30
15117115
J Rheumatol. 2007 May;34(5):1040-50
17444593
Expert Opin Drug Saf. 2005 Jul;4(4):637-41
16011443
Lancet. 2007 Jul 21;370(9583):263-271
17658397
Exp Dermatol. 2004 Apr;13(4):193-222
15086336
Dermatology. 2008;216(3):260-70
18187944
Arch Dermatol. 2006 Feb;142(2):198-202
16490847
J Am Acad Dermatol. 2008 Jan;58(1):125-35
17996329
Arthritis Rheum. 2008 Jul 15;59(7):996-1001
18576309
J Invest Dermatol. 1997 Oct;109(4):562-5
9326391
Neurology. 1999 Aug 11;53(3):457-65
10449104
Ann Rheum Dis. 2008 May;67(5):710-2
18079191
Am J Clin Dermatol. 2008;9(1):1-14
18092839
Arthritis Rheum. 2005 Oct;52(10):3279-89
16200601
Arthritis Rheum. 2001 Dec;44(12):2862-9
11762947
Dermatol Ther. 2004;17(5):427-31
15379777
Ann Rheum Dis. 1999 Nov;58 Suppl 1:I70-2
10577977
Ann Rheum Dis. 2009 Dec;68(12):1863-9
19147611
Nat Rev Drug Discov. 2003 Sep;2(9):736-46
12951580
J Am Acad Dermatol. 2008 Aug;59(2):209-17
18485527
Lancet. 2007 Jul 21;370(9583):272-284
17658398
Clin Rheumatol. 2007 Feb;26(2):261-4
16924392
J Am Acad Dermatol. 2008 Jan;58(1):106-15
17936411
Exp Dermatol. 2007 Oct;16(10):779-98
17845210
Clin Exp Dermatol. 1994 May;19(3):210-6
8033378
J Rheumatol. 2006 Jul;33(7):1447-51
16724367
Med Care. 1993 Mar;31(3):247-63
8450681
Br J Dermatol. 2007 Dec;157(6):1273-4
17916219
Dermatologica. 1978;157(4):238-44
357213
Br J Dermatol. 2008 Jul;159(1):257-8
18489593
Pharmacol Ther. 2008 Feb;117(2):244-79
18155297
Arthritis Rheum. 2007 Feb;56(2):476-88
17265483
Drugs Today (Barc). 2005 Jan;41(1):37-53
15753968
Transplantation. 1996 Mar 15;61(5):715-21
8607173
J Cutan Med Surg. 2009 Jan-Feb;13(1):48-50
19298772
Qual Life Res. 1993 Jun;2(3):169-80
8401453
Clin Dermatol. 2008 Sep-Oct;26(5):486-502
18755367
Arch Dermatol. 2007 Dec;143(12):1493-9
18086997
Br J Dermatol. 2008 Mar;158(3):558-66
18047523
Anal Biochem. 2001 Dec 15;299(2):119-29
11730333
J Am Acad Dermatol. 1999 Feb;40(2 Pt 1):177-86
10025742
Arch Dermatol. 2008 Feb;144(2):200-7
18283176
Lancet. 2008 May 17;371(9625):1665-74
18486739
Br J Dermatol. 2008 Sep;159(3):513-26
18627372
Semin Cutan Med Surg. 2005 Mar;24(1):52-7
15900799
Clin Exp Immunol. 1994 Apr;96(1):146-51
8149659
J Rheumatol. 1998 Aug;25(8):1544-52
9712099
Chest. 2007 Jun;131(6):1898-906
17565023
JAMA. 2006 Oct 11;296(14):1735-41
17032986
Rheumatology (Oxford). 2007 Apr;46(4):695-8
17158212
J Am Acad Dermatol. 2005 Nov;53(5 Suppl 1):S260-2
16227104
J Am Acad Dermatol. 2007 Aug;57(2):347-54
17433490
J Dermatolog Treat. 2005;16(5-6):350-2
16428160
J Rheumatol. 1998 Jan;25(1):105-10
9458212
J Am Acad Dermatol. 2007 Aug;57(2):269-75
17574299
Am J Pathol. 1991 Jan;138(1):129-40
1702929
Br J Dermatol. 2007 Mar;156(3):486-91
17300238
J Am Acad Dermatol. 2008 Feb;58(2 Suppl):S50-2
18191709
J Am Acad Dermatol. 1991 May;24(5 Pt 1):675-85
1869638
Am J Respir Crit Care Med. 2006 Oct 1;174(7):736-42
16799073
Med Care. 1992 Jun;30(6):473-83
1593914
Arthritis Rheum. 2008 Feb 15;59(2):234-40
18240258
J Dermatolog Treat. 2007;18(1):25-31
17365264
Lancet. 2001 Sep 29;358(9287):1042-5
11589933
Br J Dermatol. 2008 Mar;158(3):549-57
18047521
Clin Exp Dermatol. 1994 Sep;19(5):383-7
7955493
Clin Ther. 2003 Jun;25(6):1700-21
12860493
J Am Acad Dermatol. 2002 Jun;46(6):850-60
12063481
J Am Acad Dermatol. 2007 May;56(5 Suppl):S65-7
17434043
Arch Dermatol. 2008 Jun;144(6):804-6
18559778
J Invest Dermatol. 1993 Nov;101(5):701-5
7693825
Ann Rheum Dis. 2009 May;68(5):702-9
18684743
Dermatol Online J. 2006 Feb 28;12(2):4
16638397
J Neurol Sci. 2006 May 15;244(1-2):133-6
16527311
J Dermatolog Treat. 2007;18(6):341-50
18058494
Dermatology. 2006;213(2):102-10
16902286
Arch Dermatol. 2006 Dec;142(12):1654-5
17179003
Curr Drug Targets Inflamm Allergy. 2004 Jun;3(2):121-8
15180464
Ann Rheum Dis. 2007 Feb;66(2):163-8
17046964
J Am Acad Dermatol. 2006 Oct;55(4):598-606
17010738
Exp Dermatol. 2003 Aug;12(4):460-5
12930303
J Biol Regul Homeost Agents. 1997 Jul-Sep;11(3):115-8
9498161
J Am Acad Dermatol. 2008 Jun;58(6):1073-5
18485990
N Engl J Med. 2003 Apr 24;348(17):1681-91
12711744
Am J Pathol. 1991 Mar;138(3):727-39
1848044
Dermatology. 2007;215(1):17-27
17587835
J Dtsch Dermatol Ges. 2006 Nov;4 Suppl 2:S1-126
17187649
Int J Dermatol. 1993 Mar;32(3):188-90
8444530
J Investig Dermatol Symp Proc. 2004 Mar;9(2):140-7
15083781
J Manag Care Pharm. 2004 Jun;10(3 Suppl B):S38-41
15253689
Clin Infect Dis. 2006 Nov 15;43(10):e95-100
17051484
Arch Dermatol. 2008 Oct;144(10):1403-4
18936418
Nat Med. 2007 Mar;13(3):242-4
17342112
Health Qual Life Outcomes. 2008 Oct 02;6:75
18831744
Arthritis Rheum. 2005 Sep;52(9):2693-6
16142749